According to Tongbi Finance, data from Qichacha shows that based on the "Announcement of the Bidding Results for the Integrated Construction Comprehensive Service Procurement Project of the Regional Medical Laboratory Center of Jing Shan People's Hospital," Shanghai Runda Medical Technology Co., Ltd. announced on May 29, 2026, that it won the procurement project of Jing Shan People's Hospital, with a winning amount of 11.7444 million yuan.

Related listed company: Runda Medical (603108.SH)

Tongbi Finance Tip:

Runda Medical (603108.SH) reported an operating income of 6.999 billion yuan in 2025, with an operating income growth rate of -15.80%. The net profit attributable to the parent company was -548 million yuan, with a net profit growth rate of -1092.02%, and a return on equity of -13.48%.

In the first quarter of 2026, the company's operating income was 1.511 billion yuan, with an operating income growth rate of -9.11%. The net profit attributable to the parent company was -54 million yuan, with a net profit growth rate of 22.66%.

Currently, the company belongs to the healthcare industry, with the main product types being diagnostic reagents. The 2025 report shows that the main composition of its business is reagents and other consumables: 92.91%; instruments: 4.83%; software development and services: 2.15%; other businesses: 0.11%.